Hepatitis C (HCV) is the most common blood-borne pathogen in
the United States. The prevalence is estimated to be 1.8%
(approximately 4 million) of the U.S. population with
approximately 30,000 Americans acquiring HCV each year. Up to
85% of patients infected with HCV will develop chronic infection,
often asymptomatic, with a variable rate of progression to
cirrhosis, liver transplantation, hepatocellular carcinoma, or
death. Despite the availability of effective antiviral therapy for
chronic HCV, significant knowledge gaps exist among primary
care physicians, those who are most likely to encounter patients
with HCV and have the opportunity to diagnose and refer them
for treatment. Similar deficiencies have been described in primary
care training programs. We conducted this survey to assess HCVrelated knowledge among our primary care residents in the fields
of internal medicine (IM), family practice (FP), and obstetricsgynecology (OBGYN).

A 21-item questionnaire measuring core awareness and
knowledge of HCV was distributed to IM, FP, and OBGYN residents
for baseline measurement prior to a two-part HCV educational
session. Six primary constructs were addressed: self-perceived
role in caring for patients with possible HCV (SPR), screening
and diagnosis (SC), barriers to specialist referral (BR), counseling
and management (CM), treatment (TX), and contraindications to
treating HCV (CI). Constructs were reported as either group
percentages of items appropriately selected or as means of
participants’ averaged score correct on questions within that
construct. Multiple response questions were scored as number
appropriately selected by the participant divided by total number
of appropriate items for that question. Items were deemed
appropriate using the American Association for the Study of Liver
Disease Guidelines and National Institutes of Health Consensus
Statement. Data were analyzed using SPSS 11.5. Student’s
T-test was used for group comparisons with a p-value at or below
0.05 being considered statistically significant.

• 83.3% (N = 62) of participants returned questionnaires.
• Residents perceived their primary role to be that of screening (98.4%) and
diagnosis (96.8%) of HCV rather than provision of antiviral therapy
(12.9%).
• All other construct scores were below 70% regardless of specialty or postgraduate year (PGY). No significant differences were noted between
specialties or PGY groups.
• Only 50% appropriately selected ELISA/RIBA as the diagnostic test of choice
and 37.1% genotype (GT) 1 as the most common in the U.S.
• 45.2% identified pegylated interferon-alfa and ribavirin as the treatment of
choice.
• Few correctly identified the SVR rate of combination therapy in GT 1
(30.6%) and GT 2 & 3 (9.7% & 11.3%).
• More would test for exposure to HIV (98.4%) and HBV (92.1%) than HAV
(56.5%), and few knew the correct HAV vaccination schedule (16.1%).
• Most (53.2%) could not correctly identify the rate of vertical transmission
from an HCV-infected mother as <10%, and few (30.6%) were aware of
current breastfeeding recommendations.

• As in previous survey-based studies, we identified many aspects of HCV
knowledge that are lacking among our primary care residents, particularly
involving diagnostic tests, HAV vaccination recommendations, counseling,
and antiviral therapy.
• It is troubling that only half of the participants would correctly order
ELISA/RIBA to screen at-risk patients for HCV, while nearly half would order
AST/ALT. Laboratory studies are frequently within the normal range in
chronic HCV and not recommended for screening purposes.
• Because of reports that super-infection with HAV in patients with chronic
HCV has resulted in fulminant hepatitis, it is recommended that all patients
with chronic HCV and no preexisting antibody to HAV receive HAV
vaccination. Few residents were aware of this recommendation, and the
majority were unable to report the correct HAV vaccination schedule.
• Underestimating the efficacy of HCV treatment may represent a significant
barrier to diagnosis and treatment. Only half of the respondents were able
to identify the standard of care therapy (pegylated interferon-alfa and
ribavirin) and the SVR rates associated with their use.
• Knowledge of counseling recommendations regarding condom use, vertical
transmission, and the negligible risk of transmission during breastfeeding
was also lacking. This is likely due to lack of exposure to this information in
training programs.
• Future research includes plans to distribute a follow-up survey 1 to 3
months after an educational intervention for each of the residency groups.
We hope to improve knowledge regarding the care of patients infected with
HCV among our primary care residents, those who are most likely to have
the opportunity to diagnose HCV and refer patients for treatment.

